FDA Approved: MOXIFLOXACIN — Supplemental Application (Fresenius Kabi USA, LLC)

View source ↗

Summary

FDA approved a supplemental application for moxifloxacin hydrochloride (MOXIFLOXACIN) from Fresenius Kabi USA, LLC, indicating a modification to the product's a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Exacerbation of Chronic Bronchitis
• Bacterial Sinusitis
• Community-acquired Pneumonia
• Complicated Skin and Skin Structure Infections
• Intra-abdominal Infection

Drugs mentioned

• MOXIFLOXACIN HYDROCHLORIDE (moxifloxacin hydrochloride)

Snippet

SUPPL AP for MOXIFLOXACIN (MOXIFLOXACIN HYDROCHLORIDE)